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May 14, 2013:2021–6use criteria were categorized as uncertain for coronary revascular-
ization because of the equipoise of scientific evidence. Whereas we
did not find significant differences in the adjusted rates of clinical
outcomes among patients with uncertain indications, the hazard
ratio was 0.61 (95% confidence interval: 0.28 to 1.16), suggesting
a possible benefit of coronary revascularization. We believe there is
an urgent need to understand factors associated with underutili-
zation and overutilization of coronary revascularization. We also
completely agree that larger, more comprehensive studies of
patients in the uncertain category should be undertaken in the
future to more definitively assess whether these types of patients
derive benefit from coronary revascularization procedures.
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Reply
Continued debate and discussion of concerns around the appro-
priate use criteria (AUC) for revascularization such as those
expressed by Drs. Kereiakes and Stone are essential in continuing
to improve the process and application of the criteria (1). However,
the concerns expressed and perspectives should be examined in
light of the existing data with the AUC for revascularization.
With regards to the general limitations noted, several of the
lines of data and perspectives may provide the view that the AUC
glass is indeed “three-quarters full” rather than “mostly empty” as
implied by the authors. Specifically, 1) the AUC do not represent
a limited set of stakeholders, rather they involve representation
from all of the cardiovascular professional societies and several
reviewing organizations, and they represent the only existing ocriteria or recommendations that have been surveyed and found to
have over 80% agreement with interventional cardiologists who
have not gone through the evidence or review process (2).
2) Rather than “classifying a minority” patient scenario, the AUC
in their current form have been shown to categorize in the NCDR
(National Cardiovascular Data Registry) review by Chan et al. (3)
(over 80%) and in the Ko et al. (4) paper in the Journal (over 85%)
ercutaneous coronary interventions or angiograms with signifi-
ant stenosis. 3) The AUC do incorporate published lesion
haracteristics such as chronic occlusions, fractional flow reserve in
he diagnostic catheterization criteria, and the extent of ischemia
nd lesion location as clinical correlates for myocardium supplied.
inally, 4) the AUC are based on published literature for effec-
iveness of revascularization and not on NCDR data; rather, the
CDR is being used to provide feedback to sites, where the
imitations of site-entered data are highlighted by the authors.
Drs. Kereiakes and Stone also have a misunderstanding of the
UC, in that the goal of the AUC is to ensure the appropriate use
f revascularization aimed at improving patient health status and
linical outcomes, reducing both underuse and overuse. Notably,
o practice document such as the AUC or clinical practice
uidelines can capture the varied array of potential patient prefer-
nces; rather, these documents endeavor to provide the available
vidence. Just as an asymptomatic patient with low-risk ischemia
nd 1-vessel obstructive coronary disease may initially prefer a
ercutaneous coronary intervention procedure based on pre-
xisting knowledge or conceptions, another patient with critical
idespread 3-vessel coronary disease may prefer not to undergo
evascularization based on exactly opposite pre-existing knowledge
r conceptions. As such, the AUC are aimed at providing the
linician and patient the best available data and clinical consensus
n revascularization care (based on symptoms/syndrome, anatomy,
egree of ischemia, and medical therapy) so that a discussion to
nform, educate, and then elicit patient preferences may be had.
hese decisions and practice patterns are then aggregated into
opulation-based reports to centers to ensure they are consistent in
ho is offered revascularization.
Finally, the Drs. Kereiakes and Stone assert that the AUC are
imed more at overuse than underuse. Reviewing the ratings data
or the 180 clinical scenarios demonstrate that the majority of the
riteria is rated as appropriate, with a minority being rated as
nappropriate with the existing published literature demonstrating
ow rates (15%) of elective percutaneous coronary interventions
ith this categorization from multiple data sources. As stated, the
UC goal is to emphasize neither underuse nor overuse, but rather
ppropriate use. In this regard, Drs. Kereiakes and Stone are
orrect that evaluation of event rates from the uncertain group in
he study by Ko et al. (4) demonstrates that 23 (15.3%) patients
ho did not undergo revascularization had died or had recurrent
cute coronary syndromes at 3 years compared with 14 (8%) who
nderwent revascularization, potentially representing underuse in
n underpowered observation. However, as a matter of perspective,
eaders should also note in the inappropriate categorized patients
ho did not undergo revascularization, 16 (9.4%) died or had
ecurrent acute coronary syndromes at 3 years compared with 20
14.2%) who did undergo revascularization, almost the exact same
umerical finding in the opposite direction of the uncertain group,
otentially demonstrating overuse with harm in an underpowered
bservation. Hence, the report by Ko et al. (4) does provide
R2026 Correspondence JACC Vol. 61, No. 19, 2013
May 14, 2013:2021–6impetus for larger studies to better define areas both of underuse
and overuse, but more importantly these data add to the growing
data suggesting a gradient of clinical events across the rating
categories.
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